Search

Your search keyword '"Nanomedicine ' showing total 18,031 results

Search Constraints

Start Over You searched for: Author "Nanomedicine Remove constraint Author: "Nanomedicine
18,031 results on '"Nanomedicine '

Search Results

2. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo

3. Extracellular vesicles as vehicles for drug delivery to the heart

4. Exercise Inhibits Doxorubicin-Induced Cardiotoxicity via Regulating B Cells

5. Reduced uterine perfusion pressure as a model for preeclampsia and fetal growth restriction in murine: a systematic review and meta-analysis

6. Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration

7. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles

8. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

9. Assessment of feto-placental oxygenation and perfusion in a rat model of placental insufficiency using T2* mapping and 3D dynamic contrast-enhanced MRI

10. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells

11. Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro

12. Lipid nanoparticles for nucleic acid delivery beyond the liver

14. Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury

15. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

16. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes

17. Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species

18. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond

19. Extracellular vesicle-mediated protein delivery to the liver

20. Fusogenic Coiled-Coil Peptides Enhance Lipid Nanoparticle-Mediated mRNA Delivery upon Intramyocardial Administration

21. Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications

22. Cellular polyploidy in organ homeostasis and regeneration

23. Nanomedicines: An approach to treat placental insufficiency and the current challenges

24. Levodopa-loaded nanoparticles for the treatment of Parkinson's disease

25. Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles

26. Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure: A Longitudinal Observational Study

27. In-vitro and in-silico evidence for oxidative stress as drivers for RDW

28. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery

29. Factor XII Explored with AlphaFold - Opportunities for Selective Drug Development

30. EV-Elute: a universal platform for enrichment of functional surface marker-defined extracellular vesicle subpopulations

31. Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities

32. A New Open Access Journal: Molecular Biology & Nanomedicine

33. Evaluation and manipulation of tissue and cellular distribution of cardiac progenitor cell-derived extracellular vesicles

34. Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes

35. Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling

36. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models

37. Extracellular vesicles enclosed-miR-421 suppresses air pollution (PM 2.5 )-induced cardiac dysfunction via ACE2 signalling.

38. Utilizing in vitro drug release assays to predict in vivo drug retention in micelles

39. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

40. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles

41. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

42. Microlyse; a thrombolytic agent that targets VWF for clearance of microvascular thrombosis

43. Functional siRNA Delivery by Extracellular Vesicle–Liposome Hybrid Nanoparticles

44. A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs

45. Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement

46. Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity

47. Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma

48. Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery

49. Crucial Role of miR-433 in Regulating Cardiac Fibrosis: Erratum

50. Profiling of Extracellular Small RNAs Highlights a Strong Bias towards Non-Vesicular Secretion

Catalog

Books, media, physical & digital resources